Lipids for Neonates

Gastroenterology and Nutrition: Neonatology Questions and Controversies

Volumn 9781437726039, Issue , 2012, Pages 183-201

  Innis, Sheila M ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c British Columbia Children's and Women's Hospitals   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84911054051     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2603-9.00012-0     Document Type: Chapter

References (105)

1. Jensen RG Handbook of Milk Composition 1995, Academic Press, San Diego.
2. Innis SM Dietary triacylglycerol structure and its role in infant nutrition. Adv Nutr 2011, 2(3):275-283.
3. Innis S Perinatal biochemistry and physiology of long chain polyunsaturated fatty acids. J Pediatr 2003, 143:S1-S8.
4. Innis SM Essential fatty acids in growth and development. Prog Lipid Res 1991, 30:39-103.
5. Novak EM, Dyer RA, Innis SM High dietary omega-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth. Brain Res 2008, 1237:136-145.
6. Innis SM Omega-3 fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations?. J Pediatr Gastroenterol Nutr 2009, 48:S16-S24.
7. Tu WC, Cook-Johnson RJ, James MJ, et al. Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene expression. Prostaglandins Leukot Essent Fatty Acids 2010, 83:61-68.
8. Burdge GC, Jones AE, Wooton SA Eicosapentaenoic acid and docosahexaenoic acid are the principle products of alpha-linolenic acid metabolism in young men. Br J Nutr 2002, 88:355-364.
9. Pawlosky RJ, Hibbeln JR, Novotny JA, Salem N Physiological compartmental analysis of α-linolenic acid metabolism in adult humans. J Lipid Res 2001, 42:1257-1265.
10. Demmelmair H, von Schenck U, Behrendt E, et al. Estimation of arachidonic acid synthesis in full-term neonates using natural variation of 13C content. J Pediatr Gastroenterol Nutr 1995, 21:31-36.
11. Carnielli VP, Simonato M, Verlato G, et al. Synthesis of long-chain polyunsaturated fatty acids in premature newborns fed formula with long-chain polyunsaturated fatty acids. Am J Clin Nutr 2007, 86:1323-1330.
12. 13C-U-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n-3 in newborn term infants. Am J Clin Nutr 2010, 92:284-293.
13. Georgieff M, Innis SM Controversial nutrients that potentially affect preterm neurodevelopment: essential fatty acids and iron. Pediatr Res 2005, 52:99-103R.
14. Innis SM Essential fatty acid transfer and fetal development. Placenta 2005, 26:S70-S75.
15. Innis SM, Auestad N, Siegman JS Blood lipid docosahexaenoic and arachidonic acid in term gestation infants fed formulas with high docosahexaenoic acid and low eicosapentaenoic acid fish oil. Lipids 1996, 31:617-626.
16. Smithers LG, Gibson RA, McPhee A, Makrides M Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukot Essent Fatty Acids 2008, 79:141-146.
17. Gibson RA, Neumann MA, Makrides M Effect of increasing breast milk docosahexaenoic acid on plasma and erythrocyte phospholipid fatty acids and neural indices of exclusively breast fed infants. Eur J Clin Nutr 1997, 51:578-584.
18. Jensen CL, Maude M, Anderson RE, Heird WC Effect of docosahexaenoic acid supplementation of lactating women on the fatty acid composition of breast milk lipids and maternal and infant plasma phospholipids. Am J Clin Nutr 2000, 71:292-299S.
19. Glaser C, Heinrich J, Koletzko B Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism 2010, 59:993.
20. Rzehak P, Heinrich J, Klopp N, et al. Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes. Br J Nutr 2009, 101:20-26.
21. Xie L, Innis SM Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J Nutr 2008, 138:2222-2228.
22. Caspi A, Williams B, Kim-Cohen J, et al. Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci U S A 2007, 104:18860-18865.
23. Morales E, Bustamante M, Gonzalez JR, et al. Genetic variants of the FADS gene cluster and ELOVL gene Family, colostrums LC-PUFA levels, breastfeeding, and child cognition. PLoS One 2011, 6:e17181.
24. Steer CD, Davey Smith G, Emmett PM, et al. FADS2 polymorphisms modify the effect of breastfeeding on child IQ. PLoS One 2010, 5:e11570.
25. Elias SL, Innis SM Infant plasma trans, n-6, and n-3 fatty acids and conjugated linolenic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr 2001, 73:807-814.
26. Ponder DL, Innis SM, Benson JD, Siegman JS Docosahexaenoic acid status of term infants fed breast milk or infant formula containing soy oil or corn oil. Pediatr Res 1992, 32:683-688.
27. Labadaridis J, Mavridou I, Sarafidou G, et al. Carnitine supplementation and ketogenesis by small-for-date neonates on medium- and long-chain fatty acid formulae. Biol Neonate 2000, 77:25-28.
28. Baumgart S, Pereira GR, Bennet MJ Excretion of dicarboxylic acids in preterm infants fed medium- or long-chain triglycerides. J Pediatr 1994, 25:509-510.
29. Wu PY, Edmond J, Morrow JW, et al. Gastrointestinal tolerance, fat absorption, plasma ketone and urinary dicarboxylic acid levels in low-birth-weight infants fed different amounts of medium chain triglycerides in formula. J Pediatr Gastroenterol Nutr 1993, 17:145-152.
30. Shipston MJ Ion channel regulation by protein palmitoylation. J Biol Chem 2011, 286:8709-8716.
31. Salaon C, Greaves J, Chamberlain LH The intracellular dynamic of protein palmitoylation. J Biol Chem 2010, 191:1229-1238.
32. Bradshaw HB, Rimmerman N, Hu SS, et al. Novel endogenous N-acyl glycines identification and characterization. Vitam Horm 2009, 81:191205.
33. Sastry PS Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 1985, 24:169-176.
34. Svennerholm L Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res 1968, 9:570-574.
35. Carlson SE, Werkman SH, Pepples JM, et al. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci U S A 1993, 90:1073-1077.
36. Carlson SE, Werkman SH, Tolley EA Effect of long-chain fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Cin Nutr 1996, 63:687-697.
37. Makrides M, Neuman MA, Byard RW, et al. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 1994, 60:189-194.
38. Farquharson J, Jamieson EC, Abbasi KA, et al. Effect of diet on the fatty acid composition of major phospholipids of infant cerebral cortex. Arch Dis Child 1995, 72:198-203.
39. Brenna JT, Varamini B, Jensen RG, et al. Docosahexaenoic and arachidonic acid concentrations in breast milk worldwide. Am J Clin Nutr 2007, 85:1457-1464.
40. Yukas R, Pramuk K, Lien EL Human milk fatty acid composition from nine countries varies most in DHA. Lipids 2006, 41:851-858.
41. Innis SM Human milk and formula fatty acids. J Pediatr 1992, 120:S56-S61.
42. Innis SM Polyunsaturated fatty acids in human milk: an essential role in infant development. Adv Exp Med Biol 2004, 554:27-43.
43. Arbuckle LD, Rioux FM, Mackinnon MJ, et al. Response of (n-3) and (n-6) fatty acids in piglet brain, liver and plasma to increasing, but low, fish oil supplementation of formula. J Nutr 1991, 121:1536-1547.
44. Grønn M, Christensen E, Hagve TA, Christophersen BO Effects of dietary purified eicosapentaenoic acid (20:5 (n-3) ) and docosahexaenoic acid (22:6(n-3) ) on fatty acid desaturation and oxidation in isolated rat liver cells. Biochim Biophys Acta 1992, 1125:35-43.
45. Martinez M, Mougan I Fatty acid composition of human brain phospholipids during normal development. J Neurochem 1998, 71:2528-2533.
46. Martinez M Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992, 120:S129-S138.
47. Clandinin MT, Chappell JE, Heim T, et al. Fatty acid utilization in perinatal de novo synthesis of tissues. Early Human Dev. 1981;5:355-366.
48. Innis SM Dietary n-3 fatty acids and brain development. J Nutr 2007, 137:1-5.
49. Mukherjee PK, Chawla A, Loayza MS, Bazan NG Docosanoids are multifunctional regulators of neural cell integrity and fate: significance in aging and disease. Prostaglandins Leukot Essent Fatty Acids 2007, 77:233-238.
50. Pifferi F, Jouin M, Alesandri JM, et al. Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. Prostaglandins Leukotr Essent Fatty Acids 2007, 77:279-286.
51. Martinez M, Vazquez E MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. Neurology 1998, 51:26-32.
52. Jeffrey BG, Weisinger HS, Neuringer M, Mitchell DC The role of docosahexaenoic acid in retinal function. Lipids 2001, 36:859.
53. Birch EE, Carlson SE, Hoffman DR, et al. The DIAMOND (DHA Intake and Measurement of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 2010, 91:848-859.
54. Birch EE, Castañeda YS, Wheaton DH, et al. Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. Am J Clin Nutr 2005, 81:871-879.
55. Birch EE, Hoffman DR, Castañeda YS, et al. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr 2002, 75:570-580.
56. SanGiovanni JP, Parra-Cabrera S, Colditz GA, et al. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 2000, 105:1292-1298.
57. Bazan NG The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog Clin Biol Res 1989, 312:95-112.
58. Pawlik D, Lauterbach R, Turyk E Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. Pediatrics 2011, 127:223-228.
59. Calder PC The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 2008, 79:101-108.
60. Field CJ, Clandinin MT, Van Aerde JE Polyunsaturaed fatty acids and T-cell function: implications for the neonate. Lipids 2001, 36:1025-1032.
61. Serhan CN, Chiang N, Van Dyke TE Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8:349-361.
62. Field CJ, Van Aerde JE, Robinson LE, Clandinin MT Effect of providing a formula supplemented with long-chain polyunsaturated fatty acids on immunity of full-term neonates. Br J Nutr 2008, 99:91-99.
63. Field CJ, Clandinin MT, Van Aerde JE, et al. Lower proportion of CD45R0+ cells and deficient interleukin-10 production by formula-fed infants compared with human milk fed infants is corrected with supplementation with long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 2000, 31:291-299.
64. Rueda R The role of dietary gangliosides on immunity and the prevention of infection. Br J Nutr 2007, 98:S68-S73.
65. Laegreid A, Otnaess AB, Fuglesang J Human and bovine milk: comparison of ganglioside composition and enterotoxin-inhibitory activity. Pediatr Res 1986, 20:416-421.
66. McJarrow P, Schnell N, Jumpsen J, Clandinin T Influence of dietary gangliosides on neonatal brain development. Nutr Rev 2009, 67:51-63.
67. Wang B, McVeagh P, Petocz P, Brand-Miller J Brain ganglioside and glycoprotein sialic acid in breastfed compared with formula-fed infants. Am J Clin Nutr 2003, 78:1024-1029.
68. Mize CE, Uauy R, Kramer R, et al. Lipoprotein-cholesterol responses in healthy infants fed defined diets from ages 1 to 12 months: comparison of diets predominate in oleic acid versus linoleic acid, with parallel observations in infants fed a human milk-based diet. J Lipid Res 1995, 36:1178-1187.
69. Demmers TA, Jones PJH, Wang Y, et al. Effects of early cholesterol intake on cholesterol biosynthesis and plasma lipids among infants until 18 months of age. Pediatrics 2005, 115:1594-1601.
70. Owen CG, Whincup PH, Kaye SJ, et al. Does initial breastfeeding lead to lower blood cholesterol in adult life? A quantitative review of the evidence. Am J Clin Nutr 2008, 88:305-314.
71. Herz J, Chen Y, Masiulis I, Zhou L Expanding functions of lipoprotein receptors. J Lipid Res 2009, 50:S287-S292.
72. Bokor S, Koletzko B, Decsi T Systematic review of fatty acid composition of human milk from mothers of preterm compared to full-term infants. Ann Nutr Metab 2007, 51:550-556.
73. Makrides M, Neumann MA, Gibson RA Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 1996, 50:352-357.
74. Jensen CL, Voigt RG, Prager TC, et al. Effects of maternal docosahexaenoic acid supplementation of lactating women on the fatty acid composition of breast milk lipids and maternal and infant plasma phospholipids. Am J Clin Nutr 2000, 71:292-299S.
75. Phan CT, Tso P Intestinal lipid absorption and transport. Front Biosc 2001, 6:D299-319.
76. Lindquist S, Hernell O Lipid digestion and absorption in early life: an update. Curr Opin Clin Nutr Metab Care 2010, 13:314-320.
77. Jensen C, Buist NR, Wilson T Absorption of individual fatty acids from long chain or medium chain triglycerides in very small infants. Am J Clin Nutr 1986, 43:745-751.
78. Carnielli VP, Verlato G, Pederzini F, et al. Intestinal absorption of long-chain polyunsaturated fatty acids in preterm infants fed breast milk or formula. Am J Clin Nutr 1998, 67:97-103.
79. Carnielli VP, Luijendijk I, Van Goudoever JB, et al. Structural position and amount of palmitic acid in infant formulas: effects on fat, fatty acid and mineral balance. J Pediatr Gastroenterol Nutr 1996, 23:553-560.
80. Kerner JA, Poole RL The use of IV fat in neonates. Nutr Clin Pract 2006, 21:374.
81. Cunningham P, McDermott L Long chain PUFA transport in human term placenta. J Nutr 2009, 139:636.
82. 13C] docosahexaenoic and other fatty acids across the human placenta 12 h after maternal oral intake. Am J Clin Nutr 2010, 92:115-122.
83. Helland IB, Saugstad OD, Saarem K, et al. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J Matern Fetal Neonatal Med 2006, 19:397-406.
84. Dunstan JA, Mori TA, Barden A, et al. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr 2004, 58:429-437.
85. Innis SM, Friesen RW Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr 2008, 87:548-557.
86. Bhutta AT, Cleves MA, Casey PH, et al. Cognitive and behavioral outcomes of school-aged children who were born preterm: A meta-analysis. JAMA 2002, 288:728.
87. Isaacs EB, Morley R, Lucas A Early diet and general cognitive outcome at adolescence in children born at or below 30 weeks gestation. J Pediatr 2009, 155:229-237.
88. O'Connor DL, Hall R, Adamkin D, et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001, 108:359-371.
89. Fewtrell MS, Abbott RA, Kennedy K, et al. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr 2004, 144:471-479.
90. Collins CT, Makrides M, Gibson RA, et al. Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomized controlled trial. Br J Nutr 2011, 29:1-9.
91. Makrides M, Gibson RA, McPhee AJ, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 2009, 301:175-185.
92. Smithers LG, Collins CT, Simmonds, et al. Feeding preterm infants with milk with a higher dose of docosahexaenoic acid than used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial. Am J Clin Nutr 2010, 91:628-634.
93. Schulzke SM, Patole SK, Simmer K Long chain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2011, (2). CD000375.
94. Fewtrell MS, Morley R, Abbott RA, et al. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. Pediatrics 2002, 110:73-82.
95. Carpenter YA, Hacquebard M Intravenous lipid emulsions to deliver omega 3 fatty acids. PLEFA 2006, 75:145-148.
96. Wanten GJ, Calder PC Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 2007, 85:1171-1184.
97. Deshpande G, Simmer K Lipids for parenteral nutrition in neonates. Curr Opin Clin Nutr Metab Care 2011, 14:145-150.
98. A.S.P.E.N Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. J Parenter Enteral Nutr 2002, 26:106-107SA.
99. Koletzko B, Goulet O, Hunt J, et al. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN). J Pediatr Gastroenterol Nutr 2005, 41:S1-87.
100. Nelson CM, Innis SM Plasma lipoprotein fatty acids are altered by the positional distribution of fatty acids in infant formula triacylglycerols and human milk. Am J Clin Nutr 1999, 70:62-69.
101. Rochow N, Möller S, Fusch G, et al. Levels of lipids in preterm infants fed breast milk. Clin Nutr 2010, 29:94-99.
102. Diamond IR, Pencharz PB, Wales PW Omega-3 lipids for intestinal failure associated liver disease. Semin Pediatr Surg 2009, 18:239-245.
103. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009, 250:395-402.
104. Mirtallo JM, Dasta JF, Kleinschmidt KC, Varon J State of the art review. Intravenous fat emulsions: Current applications, safety profile, and clinical implications. Ann Pharmacother 2010, 44:688-700.
105. Koletzko B, Goulet O Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease. Curr Opin Clin Nutr Metab Care 2010, 13:321-326.